| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 9.16e-04 | 53 | 17 | 2 | GO:0008188 | |
| GeneOntologyMolecularFunction | E-box binding | 1.21e-03 | 61 | 17 | 2 | GO:0070888 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 2.35e-03 | 320 | 17 | 3 | GO:0001227 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 2.47e-03 | 326 | 17 | 3 | GO:0001217 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase inhibitor activity | 3.54e-03 | 105 | 17 | 2 | GO:0004867 | |
| GeneOntologyMolecularFunction | G protein-coupled peptide receptor activity | 5.61e-03 | 133 | 17 | 2 | GO:0008528 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | 5.72e-03 | 884 | 17 | 4 | GO:0004930 | |
| GeneOntologyMolecularFunction | peptide receptor activity | 6.20e-03 | 140 | 17 | 2 | GO:0001653 | |
| GeneOntologyMolecularFunction | endopeptidase inhibitor activity | 1.01e-02 | 180 | 17 | 2 | GO:0004866 | |
| GeneOntologyMolecularFunction | protease binding | 1.02e-02 | 181 | 17 | 2 | GO:0002020 | |
| GeneOntologyMolecularFunction | peptidase inhibitor activity | 1.08e-02 | 187 | 17 | 2 | GO:0030414 | |
| GeneOntologyMolecularFunction | endopeptidase regulator activity | 1.24e-02 | 201 | 17 | 2 | GO:0061135 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin D biosynthetic process | 6.38e-06 | 5 | 17 | 2 | GO:0010957 | |
| GeneOntologyBiologicalProcess | regulation of vitamin D biosynthetic process | 1.34e-05 | 7 | 17 | 2 | GO:0060556 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 2.87e-05 | 10 | 17 | 2 | GO:0046137 | |
| GeneOntologyBiologicalProcess | vitamin D biosynthetic process | 2.87e-05 | 10 | 17 | 2 | GO:0042368 | |
| GeneOntologyBiologicalProcess | cartilage morphogenesis | 4.20e-05 | 12 | 17 | 2 | GO:0060536 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion mediated by integrin | 4.20e-05 | 12 | 17 | 2 | GO:0033629 | |
| GeneOntologyBiologicalProcess | fat-soluble vitamin biosynthetic process | 5.78e-05 | 14 | 17 | 2 | GO:0042362 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA damage response, signal transduction by p53 class mediator | 7.62e-05 | 16 | 17 | 2 | GO:0043518 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 9.71e-05 | 18 | 17 | 2 | GO:0030656 | |
| GeneOntologyBiologicalProcess | epithelial to mesenchymal transition involved in endocardial cushion formation | 1.08e-04 | 19 | 17 | 2 | GO:0003198 | |
| GeneOntologyBiologicalProcess | regulation of hematopoietic stem cell proliferation | 1.20e-04 | 20 | 17 | 2 | GO:1902033 | |
| GeneOntologyBiologicalProcess | vitamin D metabolic process | 1.60e-04 | 23 | 17 | 2 | GO:0042359 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid metabolic process | 2.15e-04 | 145 | 17 | 3 | GO:0045833 | |
| GeneOntologyBiologicalProcess | regulation of bicellular tight junction assembly | 2.39e-04 | 28 | 17 | 2 | GO:2000810 | |
| GeneOntologyBiologicalProcess | vitamin biosynthetic process | 2.39e-04 | 28 | 17 | 2 | GO:0009110 | |
| GeneOntologyBiologicalProcess | negative regulation of steroid biosynthetic process | 3.13e-04 | 32 | 17 | 2 | GO:0010894 | |
| GeneOntologyBiologicalProcess | endocardial cushion formation | 3.13e-04 | 32 | 17 | 2 | GO:0003272 | |
| GeneOntologyBiologicalProcess | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 3.13e-04 | 32 | 17 | 2 | GO:1902230 | |
| GeneOntologyBiologicalProcess | negative regulation of steroid metabolic process | 3.96e-04 | 36 | 17 | 2 | GO:0045939 | |
| GeneOntologyBiologicalProcess | aortic valve morphogenesis | 4.65e-04 | 39 | 17 | 2 | GO:0003180 | |
| GeneOntologyBiologicalProcess | cardiac epithelial to mesenchymal transition | 4.90e-04 | 40 | 17 | 2 | GO:0060317 | |
| GeneOntologyBiologicalProcess | regulation of DNA damage response, signal transduction by p53 class mediator | 4.90e-04 | 40 | 17 | 2 | GO:0043516 | |
| GeneOntologyBiologicalProcess | negative regulation of signal transduction by p53 class mediator | 5.14e-04 | 41 | 17 | 2 | GO:1901797 | |
| GeneOntologyBiologicalProcess | acute inflammatory response to antigenic stimulus | 5.40e-04 | 42 | 17 | 2 | GO:0002438 | |
| GeneOntologyBiologicalProcess | hematopoietic stem cell proliferation | 5.66e-04 | 43 | 17 | 2 | GO:0071425 | |
| GeneOntologyBiologicalProcess | endocardial cushion morphogenesis | 5.93e-04 | 44 | 17 | 2 | GO:0003203 | |
| GeneOntologyBiologicalProcess | regulation of intrinsic apoptotic signaling pathway in response to DNA damage | 5.93e-04 | 44 | 17 | 2 | GO:1902229 | |
| GeneOntologyBiologicalProcess | aortic valve development | 6.48e-04 | 46 | 17 | 2 | GO:0003176 | |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 7.65e-04 | 50 | 17 | 2 | GO:1905314 | |
| GeneOntologyBiologicalProcess | regulation of cell adhesion mediated by integrin | 7.65e-04 | 50 | 17 | 2 | GO:0033628 | |
| GeneOntologyBiologicalProcess | fat-soluble vitamin metabolic process | 7.96e-04 | 51 | 17 | 2 | GO:0006775 | |
| GeneOntologyBiologicalProcess | endocardial cushion development | 1.03e-03 | 58 | 17 | 2 | GO:0003197 | |
| GeneOntologyBiologicalProcess | positive regulation of stress fiber assembly | 1.06e-03 | 59 | 17 | 2 | GO:0051496 | |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 1.21e-03 | 63 | 17 | 2 | GO:0003179 | |
| GeneOntologyBiologicalProcess | mesenchyme morphogenesis | 1.29e-03 | 65 | 17 | 2 | GO:0072132 | |
| GeneOntologyBiologicalProcess | positive regulation of actin filament bundle assembly | 1.45e-03 | 69 | 17 | 2 | GO:0032233 | |
| GeneOntologyBiologicalProcess | heart valve development | 1.85e-03 | 78 | 17 | 2 | GO:0003170 | |
| GeneOntologyBiologicalProcess | DNA damage response, signal transduction by p53 class mediator | 1.85e-03 | 78 | 17 | 2 | GO:0030330 | |
| GeneOntologyBiologicalProcess | bicellular tight junction assembly | 1.99e-03 | 81 | 17 | 2 | GO:0070830 | |
| GeneOntologyBiologicalProcess | positive regulation of cell migration | 2.10e-03 | 691 | 17 | 4 | GO:0030335 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | 2.18e-03 | 1189 | 17 | 5 | GO:0044087 | |
| GeneOntologyBiologicalProcess | tight junction assembly | 2.35e-03 | 88 | 17 | 2 | GO:0120192 | |
| GeneOntologyBiologicalProcess | regulation of cell migration | 2.36e-03 | 1211 | 17 | 5 | GO:0030334 | |
| GeneOntologyBiologicalProcess | regulation of endopeptidase activity | 2.38e-03 | 332 | 17 | 3 | GO:0052548 | |
| GeneOntologyBiologicalProcess | apical junction assembly | 2.45e-03 | 90 | 17 | 2 | GO:0043297 | |
| GeneOntologyBiologicalProcess | positive regulation of cell motility | 2.50e-03 | 725 | 17 | 4 | GO:2000147 | |
| GeneOntologyBiologicalProcess | cell adhesion mediated by integrin | 2.51e-03 | 91 | 17 | 2 | GO:0033627 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 2.51e-03 | 91 | 17 | 2 | GO:0051055 | |
| GeneOntologyBiologicalProcess | tight junction organization | 2.67e-03 | 94 | 17 | 2 | GO:0120193 | |
| GeneOntologyBiologicalProcess | positive regulation of locomotion | 2.72e-03 | 742 | 17 | 4 | GO:0040017 | |
| GeneOntologyBiologicalProcess | regulation of hormone secretion | 2.87e-03 | 355 | 17 | 3 | GO:0046883 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | 3.01e-03 | 1280 | 17 | 5 | GO:2000145 | |
| GeneOntologyBiologicalProcess | inflammatory response to antigenic stimulus | 3.20e-03 | 103 | 17 | 2 | GO:0002437 | |
| GeneOntologyBiologicalProcess | roof of mouth development | 3.26e-03 | 104 | 17 | 2 | GO:0060021 | |
| GeneOntologyBiologicalProcess | regulation of steroid biosynthetic process | 3.38e-03 | 106 | 17 | 2 | GO:0050810 | |
| GeneOntologyBiologicalProcess | regulation of stress fiber assembly | 3.45e-03 | 107 | 17 | 2 | GO:0051492 | |
| GeneOntologyBiologicalProcess | negative regulation of intracellular signal transduction | 3.49e-03 | 795 | 17 | 4 | GO:1902532 | |
| GeneOntologyBiologicalProcess | regulation of locomotion | 3.53e-03 | 1327 | 17 | 5 | GO:0040012 | |
| GeneOntologyBiologicalProcess | intrinsic apoptotic signaling pathway in response to DNA damage | 4.10e-03 | 117 | 17 | 2 | GO:0008630 | |
| GeneOntologyBiologicalProcess | regulation of peptidase activity | 4.19e-03 | 406 | 17 | 3 | GO:0052547 | |
| GeneOntologyBiologicalProcess | regulation of signal transduction by p53 class mediator | 4.24e-03 | 119 | 17 | 2 | GO:1901796 | |
| GeneOntologyBiologicalProcess | regulation of stem cell proliferation | 4.24e-03 | 119 | 17 | 2 | GO:0072091 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | 4.38e-03 | 1395 | 17 | 5 | GO:0007186 | |
| GeneOntologyBiologicalProcess | regulation of actomyosin structure organization | 4.45e-03 | 122 | 17 | 2 | GO:0110020 | |
| GeneOntologyBiologicalProcess | regulation of lipid metabolic process | 4.46e-03 | 415 | 17 | 3 | GO:0019216 | |
| GeneOntologyBiologicalProcess | regulation of actin filament bundle assembly | 4.52e-03 | 123 | 17 | 2 | GO:0032231 | |
| GeneOntologyBiologicalProcess | formation of primary germ layer | 4.60e-03 | 124 | 17 | 2 | GO:0001704 | |
| GeneOntologyBiologicalProcess | hormone secretion | 4.61e-03 | 420 | 17 | 3 | GO:0046879 | |
| GeneOntologyBiologicalProcess | negative regulation of intrinsic apoptotic signaling pathway | 4.82e-03 | 127 | 17 | 2 | GO:2001243 | |
| GeneOntologyBiologicalProcess | contractile actin filament bundle assembly | 4.82e-03 | 127 | 17 | 2 | GO:0030038 | |
| GeneOntologyBiologicalProcess | stress fiber assembly | 4.82e-03 | 127 | 17 | 2 | GO:0043149 | |
| GeneOntologyBiologicalProcess | hormone transport | 4.99e-03 | 432 | 17 | 3 | GO:0009914 | |
| GeneOntologyBiologicalProcess | epithelial cell migration | 4.99e-03 | 432 | 17 | 3 | GO:0010631 | |
| GeneOntologyBiologicalProcess | epithelium migration | 5.08e-03 | 435 | 17 | 3 | GO:0090132 | |
| GeneOntologyBiologicalProcess | fatty acid transport | 5.19e-03 | 132 | 17 | 2 | GO:0015908 | |
| GeneOntologyBiologicalProcess | vitamin metabolic process | 5.27e-03 | 133 | 17 | 2 | GO:0006766 | |
| GeneOntologyBiologicalProcess | tissue migration | 5.28e-03 | 441 | 17 | 3 | GO:0090130 | |
| GeneOntologyBiologicalProcess | regulation of steroid metabolic process | 5.42e-03 | 135 | 17 | 2 | GO:0019218 | |
| Domain | - | 1.96e-04 | 679 | 16 | 5 | 3.30.160.60 | |
| Domain | zf-C2H2 | 2.15e-04 | 693 | 16 | 5 | PF00096 | |
| Domain | Znf_C2H2/integrase_DNA-bd | 2.17e-04 | 694 | 16 | 5 | IPR013087 | |
| Domain | Serpin_CS | 3.36e-04 | 32 | 16 | 2 | IPR023795 | |
| Domain | ZINC_FINGER_C2H2_2 | 3.62e-04 | 775 | 16 | 5 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 3.66e-04 | 777 | 16 | 5 | PS00028 | |
| Domain | Znf_C2H2-like | 4.10e-04 | 796 | 16 | 5 | IPR015880 | |
| Domain | Serpin_dom | 4.26e-04 | 36 | 16 | 2 | IPR023796 | |
| Domain | Znf_C2H2 | 4.31e-04 | 805 | 16 | 5 | IPR007087 | |
| Domain | ZnF_C2H2 | 4.39e-04 | 808 | 16 | 5 | SM00355 | |
| Domain | SERPIN | 4.50e-04 | 37 | 16 | 2 | PS00284 | |
| Domain | SERPIN | 4.50e-04 | 37 | 16 | 2 | SM00093 | |
| Domain | Serpin | 4.75e-04 | 38 | 16 | 2 | PF00079 | |
| Domain | Serpin_fam | 5.01e-04 | 39 | 16 | 2 | IPR000215 | |
| Domain | GPCR_Rhodpsn_7TM | 2.12e-03 | 670 | 16 | 4 | IPR017452 | |
| Domain | 7tm_1 | 2.20e-03 | 677 | 16 | 4 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 2.29e-03 | 685 | 16 | 4 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 2.37e-03 | 691 | 16 | 4 | PS50262 | |
| Domain | GPCR_Rhodpsn | 2.38e-03 | 692 | 16 | 4 | IPR000276 | |
| Domain | zf-C2H2_6 | 2.89e-02 | 314 | 16 | 2 | PF13912 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 1.19e-04 | 18 | 13 | 2 | M225 | |
| Pathway | WP_TGFBETA_SIGNALING_IN_THYROID_CELLS_FOR_EPITHELIALMESENCHYMAL_TRANSITION | 1.33e-04 | 19 | 13 | 2 | M39370 | |
| Pathway | BIOCARTA_MTA3_PATHWAY | 1.48e-04 | 20 | 13 | 2 | MM1383 | |
| Pathway | WP_NRP1TRIGGERED_SIGNALING_IN_PANCREATIC_CANCER | 1.09e-03 | 54 | 13 | 2 | M42568 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING | 1.30e-03 | 59 | 13 | 2 | M39350 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION | 1.39e-03 | 61 | 13 | 2 | M27811 | |
| Pathway | WP_GLUCOCORTICOID_RECEPTOR_PATHWAY | 1.83e-03 | 70 | 13 | 2 | M40042 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 1.99e-03 | 73 | 13 | 2 | M638 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 3.48e-03 | 97 | 13 | 2 | MM15926 | |
| Pathway | WP_NEURAL_CREST_DIFFERENTIATION | 3.77e-03 | 101 | 13 | 2 | M39448 | |
| Pathway | WP_COMPREHENSIVE_IL17A_SIGNALING | 4.45e-03 | 110 | 13 | 2 | MM16642 | |
| Pathway | WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION | 6.34e-03 | 132 | 13 | 2 | M48110 | |
| Pathway | REACTOME_PTEN_REGULATION | 7.01e-03 | 139 | 13 | 2 | M27646 | |
| Pubmed | SNAIL Transctiption factor in prostate cancer cells promotes neurite outgrowth. | 2.25e-07 | 2 | 17 | 2 | 33132158 | |
| Pubmed | Hepatic Snai1 and Snai2 promote liver regeneration and suppress liver fibrosis in mice. | 2.25e-07 | 2 | 17 | 2 | 38451818 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 10773451 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 19046938 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 15314165 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 25092544 | ||
| Pubmed | 'Snail factors in testicular germ cell tumours and their regulation by the BMP4 signalling pathway'. | 2.25e-07 | 2 | 17 | 2 | 32441446 | |
| Pubmed | The SNAI1 and SNAI2 proteins occupy their own and each other's promoter during chondrogenesis. | 2.25e-07 | 2 | 17 | 2 | 23665016 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 33478150 | ||
| Pubmed | Modularity and reshuffling of Snail and Slug expression during vertebrate evolution. | 2.25e-07 | 2 | 17 | 2 | 12482931 | |
| Pubmed | Snail2 cooperates with Snail1 in the repression of vitamin D receptor in colon cancer. | 2.25e-07 | 2 | 17 | 2 | 19502595 | |
| Pubmed | [SNAI1 and SNAI2 - transcriptional master-regulators of epithelial-mesenchimal transition]. | 2.25e-07 | 2 | 17 | 2 | 26571812 | |
| Pubmed | Snail family transcription factors are implicated in thyroid carcinogenesis. | 2.25e-07 | 2 | 17 | 2 | 17724139 | |
| Pubmed | The transcriptional repressor Snail promotes mammary tumor recurrence. | 2.25e-07 | 2 | 17 | 2 | 16169465 | |
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 9671584 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 20046880 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 23618854 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 31393789 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 18408755 | ||
| Pubmed | 2.25e-07 | 2 | 17 | 2 | 21808237 | ||
| Pubmed | Snail is an independent prognostic predictor for progression and patient survival of gastric cancer. | 2.25e-07 | 2 | 17 | 2 | 22471696 | |
| Pubmed | Distinct EMT programs control normal mammary stem cells and tumour-initiating cells. | 2.25e-07 | 2 | 17 | 2 | 26331542 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 25784376 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 30535480 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 20138990 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 22028892 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 11994736 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 10655586 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 22974478 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 24638100 | ||
| Pubmed | SNAI1 recruits HDAC1 to suppress SNAI2 transcription during epithelial to mesenchymal transition. | 6.74e-07 | 3 | 17 | 2 | 31165775 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 19821482 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 30772441 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 9858835 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 24297167 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 26781944 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 27495232 | ||
| Pubmed | Regulation of p63 isoforms by snail and slug transcription factors in human squamous cell carcinoma. | 6.74e-07 | 3 | 17 | 2 | 20150431 | |
| Pubmed | The SLUG zinc-finger protein represses E-cadherin in breast cancer. | 6.74e-07 | 3 | 17 | 2 | 11912130 | |
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 7608171 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 28215642 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 28146149 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 26764010 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 17018611 | ||
| Pubmed | 6.74e-07 | 3 | 17 | 2 | 21809991 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 23856093 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 29434190 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 9182575 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 22820858 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 18256147 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 27995335 | ||
| Pubmed | Transcription factors Snail, Slug, Twist, and SIP1 in spindle cell carcinoma of the head and neck. | 1.35e-06 | 4 | 17 | 2 | 19381684 | |
| Pubmed | Snail1, Snail2, and E47 promote mammary epithelial branching morphogenesis. | 1.35e-06 | 4 | 17 | 2 | 21610693 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 23052737 | ||
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 28112996 | ||
| Pubmed | Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. | 1.35e-06 | 4 | 17 | 2 | 17093497 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 28349782 | ||
| Pubmed | p53 inhibits tumor cell invasion via the degradation of snail protein in hepatocellular carcinoma. | 2.25e-06 | 5 | 17 | 2 | 20385133 | |
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 22771117 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 26198055 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 25240402 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 29074488 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 27479603 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 23677639 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 27113480 | ||
| Pubmed | 2.25e-06 | 5 | 17 | 2 | 15611268 | ||
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 19784072 | ||
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 20951801 | ||
| Pubmed | Hypoxia induced the differentiation of Tbx18-positive epicardial cells to CoSMCs. | 3.37e-06 | 6 | 17 | 2 | 27456656 | |
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 14673164 | ||
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 17507657 | ||
| Pubmed | 3.37e-06 | 6 | 17 | 2 | 18799618 | ||
| Pubmed | SLUG: a new target of lymphoid enhancer factor-1 in human osteoblasts. | 3.37e-06 | 6 | 17 | 2 | 20128911 | |
| Pubmed | Ajuba LIM proteins are snail/slug corepressors required for neural crest development in Xenopus. | 3.37e-06 | 6 | 17 | 2 | 18331720 | |
| Pubmed | 4.72e-06 | 7 | 17 | 2 | 25759216 | ||
| Pubmed | 4.72e-06 | 7 | 17 | 2 | 23011797 | ||
| Pubmed | 6.29e-06 | 8 | 17 | 2 | 35236825 | ||
| Pubmed | 6.29e-06 | 8 | 17 | 2 | 18830900 | ||
| Pubmed | 6.29e-06 | 8 | 17 | 2 | 25460509 | ||
| Pubmed | 6.29e-06 | 8 | 17 | 2 | 29445069 | ||
| Pubmed | Slug is a direct Notch target required for initiation of cardiac cushion cellularization. | 6.29e-06 | 8 | 17 | 2 | 18663143 | |
| Pubmed | 6.29e-06 | 8 | 17 | 2 | 36210210 | ||
| Pubmed | 8.08e-06 | 9 | 17 | 2 | 25827072 | ||
| Pubmed | 8.08e-06 | 9 | 17 | 2 | 11221845 | ||
| Pubmed | 8.08e-06 | 9 | 17 | 2 | 21849546 | ||
| Pubmed | 1.01e-05 | 10 | 17 | 2 | 21663736 | ||
| Pubmed | Retinoic acid signaling promotes the cytoskeletal rearrangement of embryonic epicardial cells. | 1.01e-05 | 10 | 17 | 2 | 29447006 | |
| Pubmed | 1.01e-05 | 10 | 17 | 2 | 25893292 | ||
| Pubmed | 1.01e-05 | 10 | 17 | 2 | 16516838 | ||
| Pubmed | Multiple functions of Snail family genes during palate development in mice. | 1.01e-05 | 10 | 17 | 2 | 17376812 | |
| Pubmed | 1.23e-05 | 11 | 17 | 2 | 29437830 | ||
| Pubmed | Epithelial-to-mesenchymal transition in epicardium is independent of Snail1. | 1.48e-05 | 12 | 17 | 2 | 23097346 | |
| Pubmed | Bmp signaling represses Vegfa to promote outflow tract cushion development. | 1.48e-05 | 12 | 17 | 2 | 23863481 | |
| Pubmed | 1.48e-05 | 12 | 17 | 2 | 30061196 | ||
| Pubmed | 1.48e-05 | 12 | 17 | 2 | 21287656 | ||
| Pubmed | 1.48e-05 | 12 | 17 | 2 | 21945074 | ||
| Pubmed | 1.75e-05 | 13 | 17 | 2 | 11863365 | ||
| Pubmed | Neural crest-derived SEMA3C activates endothelial NRP1 for cardiac outflow tract septation. | 1.75e-05 | 13 | 17 | 2 | 26053665 | |
| Pubmed | Nfatc1 coordinates valve endocardial cell lineage development required for heart valve formation. | 2.04e-05 | 14 | 17 | 2 | 21597012 | |
| Pubmed | 2.04e-05 | 14 | 17 | 2 | 19703439 | ||
| Cytoband | 6p25 | 1.54e-05 | 16 | 17 | 2 | 6p25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p25 | 5.30e-04 | 92 | 17 | 2 | chr6p25 | |
| GeneFamily | Zinc fingers C2H2-type|SNAG transcriptional repressors | 3.29e-05 | 10 | 16 | 2 | 1259 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 2.95e-04 | 718 | 16 | 5 | 28 | |
| GeneFamily | Serpin peptidase inhibitors | 4.80e-04 | 37 | 16 | 2 | 739 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.54e-07 | 179 | 17 | 4 | 2fca4117c58824562ec80c7713fe15689a28efb3 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.54e-07 | 179 | 17 | 4 | 898425fa81526a2e00fca7a25085229ff1f31069 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-conventional_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.17e-07 | 191 | 17 | 4 | f814dc20034bafa1c0e8dfe98e58370cf3f73bee | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.17e-07 | 191 | 17 | 4 | 1155c28407ff97d950d70d53256a9fb6307a2bac | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)-DC1_L.1.2.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.17e-07 | 191 | 17 | 4 | 8947010e47218095c5032f24c41e245e7977a33d | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.95e-05 | 161 | 17 | 3 | 78cc5bc488bc47726195a649946d414e6bfabf94 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_5|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.00e-05 | 162 | 17 | 3 | 0fa93efc9c005d1e649b3f7069ae8641d6e41ed8 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_NK-NK_CD56bright_CD16-|GI_small-bowel / Manually curated celltypes from each tissue | 3.11e-05 | 164 | 17 | 3 | 36e64e4f717dd59b352c20ff9742ca1e232342bb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c02-GPR183|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.29e-05 | 167 | 17 | 3 | 4b6853efefea5178280ba7c31facda0fbd1cc469 | |
| ToppCell | CTRL-Myeloid-Monocyte|CTRL / Disease state, Lineage and Cell class | 3.35e-05 | 168 | 17 | 3 | 13dca90c7b811e4d5e8fa44f5e892e29be9787a6 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-05 | 169 | 17 | 3 | 2de213b083f57f47be58427c0ce127fee9f85caa | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Hematopoietic-Myeloid-cDC1|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.41e-05 | 169 | 17 | 3 | 4de0c60f3c163b7823f739ebda4e0afc68346628 | |
| ToppCell | CTRL-Myeloid-Monocyte|Myeloid / Disease state, Lineage and Cell class | 3.53e-05 | 171 | 17 | 3 | bfa01571516a0b24476ae06cb07f56c5579dbd70 | |
| ToppCell | PSB-critical-LOC-Lymphoid-B_cell|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.59e-05 | 172 | 17 | 3 | 57b91bcce3f122f3d3267cf4d3a3ef67842caa9a | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.91e-05 | 177 | 17 | 3 | 84930899eb2978598bc8a351cbcd9e714e46799d | |
| ToppCell | lymphoid-NK_cell-TNFRSF18+IL7R-_NK_cell|World / Lineage, cell class and subclass | 3.97e-05 | 178 | 17 | 3 | 0f95e2cd448a8e5eb23b29f57cf3321ff8b1a672 | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Hematologic|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.04e-05 | 179 | 17 | 3 | 686b9f745d290ca686b42d9505e9792c78667e6e | |
| ToppCell | COVID-19_Mild-NK_CD56bright|COVID-19_Mild / Disease condition and Cell class | 4.04e-05 | 179 | 17 | 3 | 90e7a4af195aa2332b07a9f06cde63e72ff49255 | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.04e-05 | 179 | 17 | 3 | cb880ef40c203c8bd16c4f69a70cf59f97ebbffd | |
| ToppCell | droplet-Large_Intestine-COLON_-_"PROM_Tm"-30m-Hematologic-hematopoietic_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.04e-05 | 179 | 17 | 3 | 1eb004e1a17e1f1e4337e0581e547c0f5a965e68 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.11e-05 | 180 | 17 | 3 | dcec59d66995f701d816eaeea3ed1439a2f71b73 | |
| ToppCell | BAL-Control-Myeloid-MoAM-MoAM2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.11e-05 | 180 | 17 | 3 | f3d8329b7e754c1ed89b0f39b8cd9e2ae22f6725 | |
| ToppCell | Control-Myeloid-MoAM2|Control / Disease group,lineage and cell class (2021.01.30) | 4.11e-05 | 180 | 17 | 3 | 38892483a6a5388765aec87f0119c0b9bb5c7cbd | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.11e-05 | 180 | 17 | 3 | ff34195bb7325e61fbf823c103c5e6115d8f1248 | |
| ToppCell | lymphoid-T_cell-CD8+_Effector_T_cell|lymphoid / Lineage, cell class and subclass | 4.25e-05 | 182 | 17 | 3 | d4ef4a7c0f5dc044eb5cc6c0bcf539c88b1b4fef | |
| ToppCell | cellseq-Immune-Immune_Myeloid-Myeloid_Dendritic-maDC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.32e-05 | 183 | 17 | 3 | e01dacb08a9c36cf09c0b6764ce032a7232d4cdc | |
| ToppCell | lymphoid-NK_cell-TNFRSF18+IL7R-_NK_cell|lymphoid / Lineage, cell class and subclass | 4.39e-05 | 184 | 17 | 3 | 62a3918705a3fcf3ef25c9ceb80f575a2e56ef76 | |
| ToppCell | lymphoid-T_cell-CD8+_Effector_T_cell|T_cell / Lineage, cell class and subclass | 4.39e-05 | 184 | 17 | 3 | f610f28f8319d194871a3e94210bf1c493918986 | |
| ToppCell | Control-Myeloid-cDC1|Myeloid / Disease state, Lineage and Cell class | 4.39e-05 | 184 | 17 | 3 | c6affa0b12510363258f65e46bf2d47bf4a8e75f | |
| ToppCell | tumor_Lung-Myeloid_cells-CD141+_DCs|tumor_Lung / Location, Cell class and cell subclass | 4.39e-05 | 184 | 17 | 3 | f5cad8eb358898ae536cd7a7b37d3ce19528b801 | |
| ToppCell | PBMC-Mild-cDC_8|Mild / Compartment, Disease Groups and Clusters | 4.46e-05 | 185 | 17 | 3 | 891b39c20fe9858fbba90d9ef7a253f1a0870211 | |
| ToppCell | normal_Lung-Myeloid_cells-CD141+_DCs|normal_Lung / Location, Cell class and cell subclass | 4.53e-05 | 186 | 17 | 3 | a6698a2f4edd81b67e06531ede0e207dd0309205 | |
| ToppCell | Control-Myeloid-cDC1|World / Disease state, Lineage and Cell class | 4.53e-05 | 186 | 17 | 3 | 3de803dee3ef10eb85a2b47d3f93385214e5b0ff | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.60e-05 | 187 | 17 | 3 | d17352f769c3c66601b65d060626eecff41b0482 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.60e-05 | 187 | 17 | 3 | 3d4e81183cb7f6522ae654ddac494662402aa86d | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 4.68e-05 | 188 | 17 | 3 | 5d12afb483d028ca02b3b4215131f6128e8bcd48 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-conventional_dendritic_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.68e-05 | 188 | 17 | 3 | c39083b8020ae507246959abbb299d78bcd14042 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.68e-05 | 188 | 17 | 3 | 6e7a678474715f035cc13a0e226a937688f54121 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-conventional_dendritic_cell-DC1_(conventional_dendritic_cell)-DC1_L.1.2.1.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.68e-05 | 188 | 17 | 3 | 8862ecb87fc9b95eccc527387f2332dcc92cfdc3 | |
| ToppCell | systemic_lupus_erythematosus-managed-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 4.90e-05 | 191 | 17 | 3 | de25b2a4b5daadb05a54b1262557398da6314e7f | |
| ToppCell | Control-Lymphoid-T_Cytotoxic|Lymphoid / Disease state, Lineage and Cell class | 4.90e-05 | 191 | 17 | 3 | ff7204f9b645233548cf804cf6fe0c86417be87f | |
| ToppCell | 367C-Myeloid-Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.98e-05 | 192 | 17 | 3 | 26326d7c3d907d754e85e128b7d8a52e90863f3f | |
| ToppCell | 367C-Myeloid-Monocyte-CD14+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.06e-05 | 193 | 17 | 3 | c7ecd98729419b34c14f9b387b15472c47951d2f | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.06e-05 | 193 | 17 | 3 | 704378de39e1b6f108ab5b0ecbd594d414ec8ae4 | |
| ToppCell | Control-Myeloid-MoAM5,_CCL3L1|Control / Condition, Lineage and Cell class | 5.13e-05 | 194 | 17 | 3 | a1dd264822de83a0ffaf89ca4707c6a76809359e | |
| ToppCell | Control-Myeloid-MoAM5,_CCL3L1|Myeloid / Condition, Lineage and Cell class | 5.13e-05 | 194 | 17 | 3 | 96400477d130b2403ed81c229e4e4182cc2cdc14 | |
| ToppCell | BAL-Control-Myeloid-cDC-cDC-cDC_5|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.13e-05 | 194 | 17 | 3 | 36f8ae4f2b3bf802f6ff0e9fc79e7f170f96ae8b | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.13e-05 | 194 | 17 | 3 | b0a7f5ca0c6f4f5764a8b35b5de80d82b828c66c | |
| ToppCell | 343B-Myeloid-Dendritic-cDC2|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.13e-05 | 194 | 17 | 3 | aa6c9b71006fd3863a802d112d9c3838865a52bf | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 5.21e-05 | 195 | 17 | 3 | 1992a1673b7213e25f3c76ac77da35c57daceddd | |
| ToppCell | COVID-19_Severe-Classical_Monocyte-cMono_4|COVID-19_Severe / Disease condition and Cell class | 5.21e-05 | 195 | 17 | 3 | 787ea9f38ad8e2a836222ca97f4d927f7e79517d | |
| ToppCell | metastatic_Lymph_Node-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 5.21e-05 | 195 | 17 | 3 | 7fb5c0911ff09580515d1a1827d7249d6242630c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.29e-05 | 196 | 17 | 3 | e4c76e7ad68455e51fe93ce588bcec9383f8654b | |
| ToppCell | lymphoid-T_cell-Regulatory_T_cell|World / Lineage, cell class and subclass | 5.29e-05 | 196 | 17 | 3 | 42a4d706382be33d552ece1d0598d073857a8d4e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.29e-05 | 196 | 17 | 3 | 072e0e29be4639344ead4ea6ad521e3338f5f8af | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Immune-Neutrophils|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.29e-05 | 196 | 17 | 3 | 376c5a459a484205fbb0db34936e4a6146d1f622 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 5.29e-05 | 196 | 17 | 3 | 7aa6778b78a8549dd4d0a5278ef8017334b00c38 | |
| ToppCell | tumor_Lung-T/NK_cells-CD8+/CD4+_Mixed_Th|tumor_Lung / Location, Cell class and cell subclass | 5.37e-05 | 197 | 17 | 3 | de26ca046038e34790cece24529a05d491e6f8ef | |
| ToppCell | medial-Hematologic-Myeloid_Dendritic_Type_1|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.37e-05 | 197 | 17 | 3 | 5bd2f32137fd849931e52093d630d2e7e27daf4f | |
| ToppCell | medial-Hematologic-Myeloid_Dendritic_Type_1-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.37e-05 | 197 | 17 | 3 | d9baa0be469fd8737a74b5078d30ce7d66759160 | |
| ToppCell | lymphoid-T_cell-Regulatory_T_cell|lymphoid / Lineage, cell class and subclass | 5.37e-05 | 197 | 17 | 3 | 73d5dcf076caae60ea32258b4e9dcac8979a661e | |
| ToppCell | medial-2-Hematologic-Myeloid_Dendritic_Type_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.37e-05 | 197 | 17 | 3 | 3c1147857de6a7ab6b0cf77f5a6364d4c8669693 | |
| ToppCell | mild_COVID-19-CD8+_Tem|World / disease group, cell group and cell class (v2) | 5.37e-05 | 197 | 17 | 3 | 97fead264e986d922669a6006cbcec530c697df7 | |
| ToppCell | BAL-Control-cDC_5|Control / Compartment, Disease Groups and Clusters | 5.37e-05 | 197 | 17 | 3 | 8a3fe59be3ed1f0254cc8c60b99c840193370efb | |
| ToppCell | (2)_NK/T-(22)_CD8+_T_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 5.37e-05 | 197 | 17 | 3 | 20dad8e4ed36a0185e231ddcb327725d2b2005e0 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC2-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.45e-05 | 198 | 17 | 3 | c58e2d3a21fcca9f1accccc5303ca4222b6c8432 | |
| ToppCell | tumor_Lung-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 5.45e-05 | 198 | 17 | 3 | edd8ad006c4c7516491e52cc8adad20297837e5b | |
| ToppCell | distal-3-Hematologic-Myeloid_Dendritic_Type_1|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.45e-05 | 198 | 17 | 3 | b21227c7366ef79b36048509a91d2d35fd5e4956 | |
| ToppCell | mild_COVID-19-CD8+_Tem|mild_COVID-19 / disease group, cell group and cell class (v2) | 5.45e-05 | 198 | 17 | 3 | 12847340c36a6791d8bdcb81e731e2fdeec46326 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC2|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.45e-05 | 198 | 17 | 3 | f4ff9520598ebc52b3a1f31eee766957983e16b4 | |
| ToppCell | distal-Hematologic-Myeloid_Dendritic_Type_1-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.54e-05 | 199 | 17 | 3 | 3860f30114b54abff91898308df71b8b4e05b51e | |
| ToppCell | 390C-Myeloid-Dendritic-cDC1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 5.54e-05 | 199 | 17 | 3 | 60c658e0b709a6c413e9b014a26b453cada85619 | |
| ToppCell | distal-2-Hematologic-Myeloid_Dendritic_Type_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.54e-05 | 199 | 17 | 3 | 86ee039189c75e66b97453c20a34d7fb5a31e51d | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.54e-05 | 199 | 17 | 3 | 1c12b15004fa6ca9ae72a6d6f8f9a5fdeb755bd1 | |
| ToppCell | distal-Hematologic-Myeloid_Dendritic_Type_1-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.54e-05 | 199 | 17 | 3 | 78e70852acda95d2c770cdd539a46b291f929a78 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC1|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.54e-05 | 199 | 17 | 3 | c6da5c517dbcfa621fa6dda9e0c1985ba2f3bbdb | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.54e-05 | 199 | 17 | 3 | c8c89779dda4dcfb26bf86492c2e5a4f158eb8d2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC1-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.54e-05 | 199 | 17 | 3 | b9613e88c4b752529d6ae20857744418207b0830 | |
| ToppCell | distal-Hematologic-Myeloid_Dendritic_Type_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 5.54e-05 | 199 | 17 | 3 | 6fc8c321e2ddd802b9c8edfe16e006c7d4d862fc | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-MAIT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.54e-05 | 199 | 17 | 3 | 036776a03fdd181e51cc655ed99331eec9c63f39 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_GZMK+|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.62e-05 | 200 | 17 | 3 | 7a9c3f51d4a8fda5f1b7e0be6fcf9c1c92fffe99 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD3|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.62e-05 | 200 | 17 | 3 | 6b34f2b85d4f83c1270ee151f602cba6f42042ba | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.62e-05 | 200 | 17 | 3 | 5f41906cf1585e09b150a84364d47c3e466dc5b7 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-gd_T|Control / Disease, condition lineage and cell class | 5.62e-05 | 200 | 17 | 3 | 88e502c141bbb73e62aa5830d24bd645376e5f3a | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD3-NKT|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.62e-05 | 200 | 17 | 3 | b2c5618aa1ac19423996336795dadb39ea57cda7 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Mesenchymal-Mesoderm|1m / Sample Type, Dataset, Time_group, and Cell type. | 5.62e-05 | 200 | 17 | 3 | c0ad32e9dd7f481c2665587fd8bd9fffc2e725f9 | |
| ToppCell | ILEUM-non-inflamed-(5)_Plasma-(5)_IgM_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 3.20e-04 | 70 | 17 | 2 | aa63c1b77a9fb15e75835cb3781f2d890f3fe328 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Unc5b_(MGE-derived_cortical_interneurons--Chandelier_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.49e-04 | 83 | 17 | 2 | e7f7ad1cd8b08172ef2432a80554aa8174a6c675 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Unc5b_(MGE-derived_cortical_interneurons--Chandelier_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 4.49e-04 | 83 | 17 | 2 | 33fa6e4a01be4d9945b273c884066d4bfdeaa62d | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-Gamma_Delta_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 7.58e-04 | 108 | 17 | 2 | 04bfb90634b691020f246a8afbebd3bf944d1e0e | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.30e-04 | 113 | 17 | 2 | 34ae3dec5ec7585d155ea61de6adc42aa4f45226 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.30e-04 | 113 | 17 | 2 | 79ba2eb8f85e5da4c19c838df881c18ffdc450fb | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_2|E16.5-samps / Age Group, Lineage, Cell class and subclass | 8.30e-04 | 113 | 17 | 2 | dc002185095590fc071b2f39259f8b87a757e174 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 8.30e-04 | 113 | 17 | 2 | 91d55fe6fb1c1472867d74461f5b9e4f17db01cd | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lhx6|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 8.89e-04 | 117 | 17 | 2 | 0602bbad908cb28c5093b74d717da5f2af577943 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lhx6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.35e-04 | 120 | 17 | 2 | a4e3f9a83bc52ccc75bcd64b1be4e2c5441f6d1a | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.16e-03 | 134 | 17 | 2 | a3547a68012d879d4dfe80394eace70808722e43 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Col3a1_(Mural.Rgs5Acta2.Col3a1)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.16e-03 | 134 | 17 | 2 | 9458e2d0dbc18d9025b66b59f3ecc2fbc5384940 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Vipr2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.27e-03 | 140 | 17 | 2 | 72c272f44e5600b3037c1dbf9d3a4669a35588d8 | |
| ToppCell | droplet-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.27e-03 | 140 | 17 | 2 | d91ab34d6fded8c39d0f4456ce73281334660f74 | |
| Drug | AP-5 | 2.14e-06 | 128 | 17 | 4 | CID000001216 | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 7.76e-06 | 177 | 17 | 4 | 5945_UP | |
| Drug | Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 1.21e-05 | 198 | 17 | 4 | 5797_UP | |
| Drug | AC1Q5IQA | 1.47e-05 | 8 | 17 | 2 | CID000163732 | |
| Drug | d(CH2)5-Davp | 1.88e-05 | 9 | 17 | 2 | CID000123750 | |
| Drug | Naam | 2.35e-05 | 10 | 17 | 2 | CID000006861 | |
| Drug | 2,4-dihydroxybenzophenone | 3.45e-05 | 12 | 17 | 2 | ctd:C121479 | |
| Drug | AC1O532U | 6.26e-05 | 16 | 17 | 2 | CID006451282 | |
| Drug | nitric oxide | 8.63e-05 | 1075 | 17 | 6 | CID000145068 | |
| Drug | Tacrolimus | 9.86e-05 | 339 | 17 | 4 | ctd:D016559 | |
| Drug | SL-U | 1.32e-04 | 23 | 17 | 2 | CID006420153 | |
| Drug | SureCN4397131 | 1.43e-04 | 24 | 17 | 2 | CID011589428 | |
| Drug | AC1L19DA | 1.69e-04 | 26 | 17 | 2 | CID000000497 | |
| Drug | AC1L1BL0 | 1.69e-04 | 26 | 17 | 2 | CID000001484 | |
| Drug | embelin | 1.82e-04 | 27 | 17 | 2 | ctd:C010945 | |
| Drug | 5-hydroxytetralin | 1.96e-04 | 28 | 17 | 2 | CID000068258 | |
| Drug | ammonium phosphate | 1.96e-04 | 28 | 17 | 2 | CID000024402 | |
| Drug | GDP-b-S | 2.23e-04 | 162 | 17 | 3 | CID000643998 | |
| Drug | ethylchlorocarbonate | 2.41e-04 | 31 | 17 | 2 | CID000010928 | |
| Drug | MG-262; Up 200; 0.1uM; MCF7; HT_HG-U133A | 2.57e-04 | 170 | 17 | 3 | 7063_UP | |
| Drug | phenylbiguanide | 2.90e-04 | 34 | 17 | 2 | CID000004780 | |
| Drug | sarpogrelate | 2.90e-04 | 34 | 17 | 2 | CID000005160 | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 3.00e-04 | 179 | 17 | 3 | 5903_UP | |
| Drug | Rp-8-CPT-cAMPS | 3.08e-04 | 35 | 17 | 2 | CID010413188 | |
| Drug | Menadione [58-27-5]; Up 200; 23.2uM; PC3; HT_HG-U133A | 3.10e-04 | 181 | 17 | 3 | 4662_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 3.15e-04 | 182 | 17 | 3 | 6879_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 3.30e-04 | 185 | 17 | 3 | 5935_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 3.35e-04 | 186 | 17 | 3 | 6891_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 3.41e-04 | 187 | 17 | 3 | 5976_UP | |
| Drug | Proscillaridin A [466-06-8]; Down 200; 7.6uM; HL60; HT_HG-U133A | 3.57e-04 | 190 | 17 | 3 | 2920_DN | |
| Drug | Strophanthidin [66-28-4]; Down 200; 9.8uM; HL60; HT_HG-U133A | 3.57e-04 | 190 | 17 | 3 | 2525_DN | |
| Drug | Bufexamac [2438-72-4]; Up 200; 18uM; MCF7; HT_HG-U133A | 3.79e-04 | 194 | 17 | 3 | 7413_UP | |
| Drug | Dipyrone [5907-38-0]; Up 200; 12uM; PC3; HT_HG-U133A | 3.79e-04 | 194 | 17 | 3 | 4310_UP | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 3.79e-04 | 194 | 17 | 3 | 2787_DN | |
| Drug | Fluspirilen [1841-19-6]; Up 200; 8.4uM; PC3; HT_HG-U133A | 3.85e-04 | 195 | 17 | 3 | 6662_UP | |
| Drug | trichostatin A; Up 200; 0.1uM; HL60; HG-U133A | 3.85e-04 | 195 | 17 | 3 | 364_UP | |
| Drug | radicicol; Down 200; 0.1uM; HL60; HG-U133A | 3.85e-04 | 195 | 17 | 3 | 544_DN | |
| Drug | Xylazine [7361-61-7]; Up 200; 18.2uM; PC3; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 4066_UP | |
| Drug | carmustine; Up 200; 100uM; MCF7; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 6888_UP | |
| Drug | Tetracycline hydrochloride [64-75-5]; Up 200; 8.4uM; PC3; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 5757_UP | |
| Drug | Enoxacin [74011-58-8]; Down 200; 12.4uM; HL60; HG-U133A | 3.91e-04 | 196 | 17 | 3 | 1597_DN | |
| Drug | Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; PC3; HT_HG-U133A | 3.91e-04 | 196 | 17 | 3 | 2097_UP | |
| Drug | clozapine; Up 200; 10uM; MCF7; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 6988_UP | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Up 200; 6.2uM; HL60; HG-U133A | 3.97e-04 | 197 | 17 | 3 | 1776_UP | |
| Drug | Berberine chloride [633-65-8]; Up 200; 10.8uM; HL60; HG-U133A | 3.97e-04 | 197 | 17 | 3 | 1778_UP | |
| Drug | Propidium iodide [25535-16-4]; Up 200; 6uM; PC3; HT_HG-U133A | 3.97e-04 | 197 | 17 | 3 | 5803_UP | |
| Drug | Ergocryptine-alpha [511-09-1]; Down 200; 7uM; MCF7; HT_HG-U133A | 4.03e-04 | 198 | 17 | 3 | 3434_DN | |
| Drug | (-)-Cinchonidine [485-71-2]; Up 200; 13.6uM; HL60; HG-U133A | 4.09e-04 | 199 | 17 | 3 | 1780_UP | |
| Drug | Acebutolol hydrochloride [34381-68-5]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 1493_DN | |
| Drug | Domperidone maleate; Up 200; 7.4uM; MCF7; HT_HG-U133A | 4.09e-04 | 199 | 17 | 3 | 2655_UP | |
| Drug | monastrol; Down 200; 100uM; PC3; HG-U133A | 4.09e-04 | 199 | 17 | 3 | 668_DN | |
| Drug | Dextromethorphan hydrobromide monohydrate [6700-34-1]; Up 200; 10.8uM; HL60; HT_HG-U133A | 4.15e-04 | 200 | 17 | 3 | 1281_UP | |
| Drug | Rp-8-Br-cGMPS | 5.33e-04 | 46 | 17 | 2 | CID003035839 | |
| Drug | utyramide | 5.56e-04 | 47 | 17 | 2 | CID000461280 | |
| Drug | AC1L1DS5 | 5.80e-04 | 48 | 17 | 2 | CID000002483 | |
| Drug | 62 p | 6.04e-04 | 49 | 17 | 2 | CID006420118 | |
| Drug | AC1N1QTU | 7.07e-04 | 53 | 17 | 2 | CID003985498 | |
| Drug | SIN-1 chloride | 7.07e-04 | 53 | 17 | 2 | CID000065388 | |
| Drug | L-NNA | 7.40e-04 | 244 | 17 | 3 | CID000004367 | |
| Drug | NSC36900 | 7.89e-04 | 56 | 17 | 2 | CID000235484 | |
| Drug | trequinsin | 8.46e-04 | 58 | 17 | 2 | CID000005537 | |
| Drug | SNAG | 8.76e-04 | 59 | 17 | 2 | CID000177324 | |
| Drug | flunitrazepam | 8.76e-04 | 59 | 17 | 2 | CID000003380 | |
| Disease | glutaroyl carnitine measurement | 1.88e-05 | 13 | 15 | 2 | EFO_0021005 | |
| Disease | heart function measurement | 1.34e-04 | 34 | 15 | 2 | EFO_0004311 | |
| Disease | ghrelin measurement | 2.80e-04 | 49 | 15 | 2 | EFO_0600001 | |
| Disease | birth weight, pelvic organ prolapse | 2.80e-04 | 49 | 15 | 2 | EFO_0004344, EFO_0004710 | |
| Disease | Familial Nonmedullary Thyroid Cancer | 4.34e-04 | 61 | 15 | 2 | C3501844 | |
| Disease | Nonmedullary Thyroid Carcinoma | 4.34e-04 | 61 | 15 | 2 | C3501843 | |
| Disease | carcinoma (implicated_via_orthology) | 4.77e-04 | 64 | 15 | 2 | DOID:305 (implicated_via_orthology) | |
| Disease | Papillary thyroid carcinoma | 8.60e-04 | 86 | 15 | 2 | C0238463 | |
| Disease | complement factor D measurement | 1.00e-03 | 93 | 15 | 2 | EFO_0020283 | |
| Disease | Vitiligo | 1.18e-03 | 101 | 15 | 2 | EFO_0004208 | |
| Disease | Sclerocystic Ovaries | 2.38e-03 | 144 | 15 | 2 | C1136382 | |
| Disease | Polycystic Ovary Syndrome | 2.38e-03 | 144 | 15 | 2 | C0032460 | |
| Disease | colorectal cancer (is_marker_for) | 2.82e-03 | 157 | 15 | 2 | DOID:9256 (is_marker_for) | |
| Disease | Neoplasm Invasiveness | 3.85e-03 | 184 | 15 | 2 | C0027626 | |
| Disease | breast cancer (is_marker_for) | 3.89e-03 | 185 | 15 | 2 | DOID:1612 (is_marker_for) | |
| Disease | Neoplasm Metastasis | 5.31e-03 | 217 | 15 | 2 | C0027627 | |
| Disease | R-warfarin measurement | 7.81e-03 | 265 | 15 | 2 | EFO_0803324 | |
| Disease | Hereditary Diffuse Gastric Cancer | 9.47e-03 | 293 | 15 | 2 | C1708349 | |
| Disease | Stomach Neoplasms | 9.72e-03 | 297 | 15 | 2 | C0038356 | |
| Disease | Malignant neoplasm of stomach | 9.91e-03 | 300 | 15 | 2 | C0024623 | |
| Disease | platelet crit | 1.14e-02 | 952 | 15 | 3 | EFO_0007985 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DFHHLRPRFQRACPC | 471 | Q2TAZ0 | |
| PHFFCDHRPLLRASC | 181 | Q8NGR6 | |
| DCRPFLAFCRRHVRA | 31 | Q05923 | |
| RPDAFHRCIFLFCCR | 71 | Q16342 | |
| QDPPRGFFFHLCRFC | 41 | Q13370 | |
| RFCAICDRYPHLPRS | 316 | Q11130 | |
| LGSHFRQAFRRVCPC | 326 | Q969F8 | |
| RACFPFAFCRDCQFP | 381 | A4D2B8 | |
| RLPFCARKVPHFFCD | 176 | P30954 | |
| RFRLGFKHAFRCCPF | 311 | P25103 | |
| KPFSCPHCNRAFADR | 211 | O43623 | |
| RCARFVPRFCADHPF | 341 | P35237 | |
| DRPFVCPDCGKAFRH | 456 | Q9BWE0 | |
| KPFSCPHCSRAFADR | 206 | O95863 | |
| GPRFCADHPFLFFIR | 346 | P50453 | |
| FRCPHCPFITRREKA | 836 | P52746 | |
| PAQAHRRCPFCRALF | 2706 | Q15911 |